Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ardizzoni

Showing results (91-100 of 156) with videos related to

Pageof 16
Sort By:
Cancer|May 15, 1997
Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task ForceM C Pennucci, A Ardizzoni, P Pronzato, et al.
American Journal of Clinical Oncology|February 1, 1989
Recombinant alpha-2a interferon plus vinblastine in the treatment of metastatic renal cell carcinomaM R Sertoli, I Brunetti, A Ardizzoni, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|February 1, 1987
Metastatic breast cancer: an analysis of prognostic factors in patients treated with aminoglutethimideL Repetto, P Pronzato, A Ardizzoni, et al.
American Journal of Clinical Oncology|October 1, 1988
Chemotherapy of advanced non-small-cell lung cancer with cyclophosphamide, adriamycin, methotrexate, and procarbazine versus cisplatin and etoposide. A randomized studyA Veronesi, M D Magri, U Tirelli, et al.
Cancer Treatment Reports|July 1, 1986
Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lungA Ardizzoni, L Canobbio, P Pronzato, et al.
Acta Gastro-Enterologica Belgica|October 2, 2021
Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: a case seriesS Brocchi, A Parmeggiani, C Gaudiano, et al.
Cancer Investigation|January 1, 1988
Cisplatin and etoposide as second-line chemotherapy in patients with small cell lung cancerF Figoli, A Veronesi, A Ardizzoni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872A S Planting, A Ardizzoni, J Estapé, et al.
Lung Cancer (Amsterdam, Netherlands)|November 1, 1994
Induction therapy for stage III NSCLC: a consensus reportM R Green, R Ginsberg, A Ardizzoni, et al.
Cancer|March 1, 1994
Biologic and clinical effects of continuous infusion interleukin-2 in patients with non-small cell lung cancerA Ardizzoni, M Bonavia, M Viale, et al.
Pageof 16

Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Cancer|May 15, 1997
Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task ForceM C Pennucci, A Ardizzoni, P Pronzato, et al.
American Journal of Clinical Oncology|February 1, 1989
Recombinant alpha-2a interferon plus vinblastine in the treatment of metastatic renal cell carcinomaM R Sertoli, I Brunetti, A Ardizzoni, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|February 1, 1987
Metastatic breast cancer: an analysis of prognostic factors in patients treated with aminoglutethimideL Repetto, P Pronzato, A Ardizzoni, et al.
American Journal of Clinical Oncology|October 1, 1988
Chemotherapy of advanced non-small-cell lung cancer with cyclophosphamide, adriamycin, methotrexate, and procarbazine versus cisplatin and etoposide. A randomized studyA Veronesi, M D Magri, U Tirelli, et al.
Cancer Treatment Reports|July 1, 1986
Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lungA Ardizzoni, L Canobbio, P Pronzato, et al.
Acta Gastro-Enterologica Belgica|October 2, 2021
Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: a case seriesS Brocchi, A Parmeggiani, C Gaudiano, et al.
Cancer Investigation|January 1, 1988
Cisplatin and etoposide as second-line chemotherapy in patients with small cell lung cancerF Figoli, A Veronesi, A Ardizzoni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872A S Planting, A Ardizzoni, J Estapé, et al.
Lung Cancer (Amsterdam, Netherlands)|November 1, 1994
Induction therapy for stage III NSCLC: a consensus reportM R Green, R Ginsberg, A Ardizzoni, et al.
Cancer|March 1, 1994
Biologic and clinical effects of continuous infusion interleukin-2 in patients with non-small cell lung cancerA Ardizzoni, M Bonavia, M Viale, et al.
Pageof 16